MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970. doi: 10.15585/mmwr.mm6929e2.
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in many communities throughout the United States. Although case-based and syndromic surveillance are critical for monitoring the pandemic, these systems rely on persons obtaining testing or reporting a COVID-19-like illness. Using serologic tests to detect the presence of SARS-CoV-2 antibodies is an adjunctive strategy that estimates the prevalence of past infection in a population. During April 28-May 3, 2020, coinciding with the end of a statewide shelter-in-place order, CDC and the Georgia Department of Public Health conducted a serologic survey in DeKalb and Fulton counties in metropolitan Atlanta to estimate SARS-CoV-2 seroprevalence in the population. A two-stage cluster sampling design was used to randomly select 30 census blocks in each county, with a target of seven participating households per census block. Weighted estimates were calculated to account for the probability of selection and adjusted for age group, sex, and race/ethnicity. A total of 394 households and 696 persons participated and had a serology result; 19 (2.7%) of 696 persons had SARS-CoV-2 antibodies detected. The estimated weighted seroprevalence across these two metropolitan Atlanta counties was 2.5% (95% confidence interval [CI] = 1.4-4.5). Non-Hispanic black participants more commonly had SARS-CoV-2 antibodies than did participants of other racial/ethnic groups (p<0.01). Among persons with SARS-CoV-2 antibodies, 13 (weighted % = 49.9; 95% CI = 24.4-75.5) reported a COVID-19-compatible illness,* six (weighted % = 28.2; 95% CI = 11.9-53.3) sought medical care for a COVID-19-compatible illness, and five (weighted % = 15.7; 95% CI = 5.1-39.4) had been tested for SARS-CoV-2 infection, demonstrating that many of these infections would not have been identified through case-based or syndromic surveillance. The relatively low seroprevalence estimate in this report indicates that most persons in the catchment area had not been infected with SARS-CoV-2 at the time of the survey. Continued preventive measures, including social distancing, consistent and correct use of face coverings, and hand hygiene, remain critical in controlling community spread of SARS-CoV-2.
在美国许多社区,2019 年冠状病毒病(COVID-19)的病毒 SARS-CoV-2 仍在持续传播。虽然基于病例和综合征的监测对于监测大流行至关重要,但这些系统依赖于人们接受检测或报告 COVID-19 样疾病。使用血清学检测来检测 SARS-CoV-2 抗体的存在是一种辅助策略,可估计人群中过去感染的流行率。2020 年 4 月 28 日至 5 月 3 日,CDC 和佐治亚州公共卫生部在亚特兰大都市的迪卡尔布和富尔顿县进行了一项血清学调查,以估计该人群中 SARS-CoV-2 的血清流行率。采用两阶段聚类抽样设计随机选择每个县的 30 个普查区,每个普查区目标为 7 户参与家庭。加权估计数用于考虑选择的可能性,并根据年龄组、性别和种族/族裔进行调整。共有 394 户家庭和 696 人参与并获得了血清学结果;696 人中的 19 人(2.7%)检测到 SARS-CoV-2 抗体。这两个亚特兰大都市县的估计加权血清流行率为 2.5%(95%置信区间[CI]为 1.4-4.5)。与其他种族/族裔群体相比,非西班牙裔黑人参与者更常见地具有 SARS-CoV-2 抗体(p<0.01)。在具有 SARS-CoV-2 抗体的人群中,有 13 人(加权%=49.9;95%CI=24.4-75.5)报告了 COVID-19 相符的疾病*,有 6 人(加权%=28.2;95%CI=11.9-53.3)因 COVID-19 相符的疾病寻求医疗护理,有 5 人(加权%=15.7;95%CI=5.1-39.4)接受了 SARS-CoV-2 感染检测,表明其中许多感染将不会通过基于病例或综合征的监测识别。本报告中的相对较低的血清流行率估计表明,在调查时,该监测区域的大多数人尚未感染 SARS-CoV-2。继续采取预防措施,包括保持社交距离、持续正确使用口罩和保持手部卫生,对于控制 SARS-CoV-2 在社区中的传播仍然至关重要。